Apic Bio Competitors and Similar CompaniesClear all
FinVector's competitors and similar companies include Stoke Therapeutics and Grindeks.
 Stoke Therapeutics Stoke Therapeutics is a developer of antisense oligonucleotide medicines that target ribonucleic acid (RNA) splicing to enhance gene expression for the treatment of genetic diseases. |  Grindeks Grindeks, a pharmaceutical company, engages in the research, development, manufacture, and sale of generics and active pharmaceutical ingredients. | ||
Founding Date | Founding Date 2013 | Founding Date 2014 | Founding Date 1991 |
Type | Type Private | Type Public | Type Private |
Tags | |||
Locations | Locations Kuopio, FI HQ | Locations Bedford, US HQ Cambridge, US | |
Employees | Employees 338 | Employees 1106% decrease | Employees 1,505 |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $184.4m (FY, 2025) | Revenue (est.) €141.4m (FY, 2019) |
Net income | Net income N/A | Net income ($6.9m) (FY, 2025) | Net income €13.5m (FY, 2019) |
For sources of this data, please see the company profile
View Company Profiles
Stoke Therapeutics
HQ
Bedford, US
Employees
110↓ 6% decrease
Stoke Therapeutics is a developer of antisense oligonucleotide medicines that target ribonucleic acid (RNA) splicing to enhance gene expression for the treatment of genetic diseases.
View companyGrindeks
HQ
Rīga, LV
Employees
1,505
Grindeks, a pharmaceutical company, engages in the research, development, manufacture, and sale of generics and active pharmaceutical ingredients.
View company